In vivo interferon-γ therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae

John H. Rex, John E. Bennett, John I. Gallin, Harry L. Malech, Ellen S. DeCarlo, David A. Melnick

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'In vivo interferon-γ therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae'. Together they form a unique fingerprint.

Medicine & Life Sciences